Cargando…

Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis

BACKGROUND: The majority of existing studies aimed at investigating the incidence and prevalence of multidrug-resistance by bacteria have been performed in healthcare settings. Relatively few studies have been conducted in community settings, but these have consistently shown a high prevalence of mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkansa-Gyamfi, Nana Adoma, Kazibwe, Joseph, Traore, Daouda A. K., Nji, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782630/
https://www.ncbi.nlm.nih.gov/pubmed/32909519
http://dx.doi.org/10.1080/16549716.2020.1815272
_version_ 1783631944078065664
author Nkansa-Gyamfi, Nana Adoma
Kazibwe, Joseph
Traore, Daouda A. K.
Nji, Emmanuel
author_facet Nkansa-Gyamfi, Nana Adoma
Kazibwe, Joseph
Traore, Daouda A. K.
Nji, Emmanuel
author_sort Nkansa-Gyamfi, Nana Adoma
collection PubMed
description BACKGROUND: The majority of existing studies aimed at investigating the incidence and prevalence of multidrug-resistance by bacteria have been performed in healthcare settings. Relatively few studies have been conducted in community settings, but these have consistently shown a high prevalence of multidrug-resistant bacteria in low- and middle-income countries (LMICs). OBJECTIVES: To provide an appraisal of the evidence on the high prevalence of multidrug-, extensive drug-, and pandrug-resistance in commensal Escherichia coli isolates from human sources in community settings in LMICs. METHODS: Using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, PubMed, EMBASE, MEDLINE, Web of Science, CINAHL, and Cochrane Library databases were systematically searched with the search string: ‘Enterobacteriaceae’, OR ‘E. coli’, OR ‘Escherichia coli’, AND ‘antibiotic resistance’, OR ‘antimicrobial resistance’, OR ‘drug-resistance’, AND ‘prevalence’, OR ‘incidence’, OR ‘morbidity’, OR ‘odds ratio’, OR ‘risk ratio’, OR ‘confidence interval’, OR ‘p-value’, OR ‘rate’. Data were extracted and proportional meta-analysis was performed using the Freeman–Tukey transformation random effect model. RESULTS: The prevalence of multidrug-, extensive drug- and pandrug-resistance were extracted from articles that met our inclusion criteria and pooled together after a systematic screening of 9,369 items. The prevalence of multidrug-resistance was 28% of 14,336 total cases of isolates tested, 95% CI: 23–32. Extensive drug-resistance was 24% of 8,686 total cases of isolates tested, 95% CI: 14–36. Lastly, pandrug-resistance was 5% of 5,670 total cases of isolates tested, 95% CI: 3–8. CONCLUSION: This paper provides an appraisal of the evidence on the high prevalence of multidrug-, extensive drug- and pandrug-resistance by commensal E. coli in community settings in LMICs. Our results call for greater effort to be placed at the community level in the design of new and improved public health policies to counter the global threat of antibiotic-resistant infections and bacteria.
format Online
Article
Text
id pubmed-7782630
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-77826302021-01-14 Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis Nkansa-Gyamfi, Nana Adoma Kazibwe, Joseph Traore, Daouda A. K. Nji, Emmanuel Glob Health Action Review Articles BACKGROUND: The majority of existing studies aimed at investigating the incidence and prevalence of multidrug-resistance by bacteria have been performed in healthcare settings. Relatively few studies have been conducted in community settings, but these have consistently shown a high prevalence of multidrug-resistant bacteria in low- and middle-income countries (LMICs). OBJECTIVES: To provide an appraisal of the evidence on the high prevalence of multidrug-, extensive drug-, and pandrug-resistance in commensal Escherichia coli isolates from human sources in community settings in LMICs. METHODS: Using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, PubMed, EMBASE, MEDLINE, Web of Science, CINAHL, and Cochrane Library databases were systematically searched with the search string: ‘Enterobacteriaceae’, OR ‘E. coli’, OR ‘Escherichia coli’, AND ‘antibiotic resistance’, OR ‘antimicrobial resistance’, OR ‘drug-resistance’, AND ‘prevalence’, OR ‘incidence’, OR ‘morbidity’, OR ‘odds ratio’, OR ‘risk ratio’, OR ‘confidence interval’, OR ‘p-value’, OR ‘rate’. Data were extracted and proportional meta-analysis was performed using the Freeman–Tukey transformation random effect model. RESULTS: The prevalence of multidrug-, extensive drug- and pandrug-resistance were extracted from articles that met our inclusion criteria and pooled together after a systematic screening of 9,369 items. The prevalence of multidrug-resistance was 28% of 14,336 total cases of isolates tested, 95% CI: 23–32. Extensive drug-resistance was 24% of 8,686 total cases of isolates tested, 95% CI: 14–36. Lastly, pandrug-resistance was 5% of 5,670 total cases of isolates tested, 95% CI: 3–8. CONCLUSION: This paper provides an appraisal of the evidence on the high prevalence of multidrug-, extensive drug- and pandrug-resistance by commensal E. coli in community settings in LMICs. Our results call for greater effort to be placed at the community level in the design of new and improved public health policies to counter the global threat of antibiotic-resistant infections and bacteria. Taylor & Francis 2020-09-10 /pmc/articles/PMC7782630/ /pubmed/32909519 http://dx.doi.org/10.1080/16549716.2020.1815272 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Nkansa-Gyamfi, Nana Adoma
Kazibwe, Joseph
Traore, Daouda A. K.
Nji, Emmanuel
Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
title Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
title_full Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
title_fullStr Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
title_full_unstemmed Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
title_short Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
title_sort prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782630/
https://www.ncbi.nlm.nih.gov/pubmed/32909519
http://dx.doi.org/10.1080/16549716.2020.1815272
work_keys_str_mv AT nkansagyamfinanaadoma prevalenceofmultidrugextensivedrugandpandrugresistantcommensalescherichiacoliisolatedfromhealthyhumansincommunitysettingsinlowandmiddleincomecountriesasystematicreviewandmetaanalysis
AT kazibwejoseph prevalenceofmultidrugextensivedrugandpandrugresistantcommensalescherichiacoliisolatedfromhealthyhumansincommunitysettingsinlowandmiddleincomecountriesasystematicreviewandmetaanalysis
AT traoredaoudaak prevalenceofmultidrugextensivedrugandpandrugresistantcommensalescherichiacoliisolatedfromhealthyhumansincommunitysettingsinlowandmiddleincomecountriesasystematicreviewandmetaanalysis
AT njiemmanuel prevalenceofmultidrugextensivedrugandpandrugresistantcommensalescherichiacoliisolatedfromhealthyhumansincommunitysettingsinlowandmiddleincomecountriesasystematicreviewandmetaanalysis